We reviewed the chart of Pfizer (PFE) on Aug. 19 and wrote that "We looked at the charts of PFE on July 28 and gave targets of $61 and $94. Today we offer $54 in addition to $61. Longer-term the $94 to $104 area is a target."
More from Investing
The major indexes held up well, but underneath, it wasn't pretty.
Summer is a time when this name usually gains momentum. Will it this time?
Homeowners equity has more than tripled in the last decade.
With a CEO change in the mix, shares hit, and a social media under watch, let's see whether PINS could move the needle.